Frontlight ResearchEarly access
WithdrawnNo phase
Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer
Key facts
- Who runs it
- Barbara Ann Karmanos Cancer Institute
- Where
- Detroit, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 25 Jul 2023
- Ended
- 24 Aug 2024
- Type of study
- Interventional
- Treatments tested
- Monitoring Device
- Quality-of-Life Assessment
- Questionnaire Administration
- Record updated
- 4 October 2023
- Why it stopped
- No accrual
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Locally advanced (stage III-IVb) and metastatic (stage IVc) HNSCC who are referred to medical oncology. Patients may not have received upfront definitive surgical resection of the primary tumor or upfront neck dissection
- Patients must be able to operate the home sleep study device
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
Who cannot take part
- Patients should not have received any prior systemic chemotherapy or radiation therapy for locally advanced or metastatic HNSCC
- Patients with tracheostomy or those requiring the assistance of a ventilator will be ineligible for the study
Where in United States
- Barbara Ann Karmanos Cancer InstituteDetroit, United States
About the trial
What the trial wants to find out
This trial studies information from a home sleep apnea machine to evaluate obstructive sleep apnea in patients with stage III-IV head and neck cancer. Sleep apnea (trouble breathing during sleep) can occur in head and neck cancer patients who have swelling in their neck. Wearing a sleep apnea machine overnight may help doctors evaluate obstructive sleep apnea in patients with head and neck cancer.
The group in the trial
- Monitoring device, Quality of Life Assessment, QuestionnaireTreatment being tested
Patients wear the home sleep apnea machine overnight. Patients undergoing standard of care CRT wear the home sleep apnea machine a second time 3 months after completion of CRT.
Treatment: Monitoring Device, Quality-of-Life Assessment, and Questionnaire Administration
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of Obstructive Sleep Apnea in Head and Neck Cancer
- Record updated
- 4 October 2023